Cargando…
Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in immunocompromised individuals is associated with prolonged virus shedding and evolution of viral variants. Rapamycin and its analogs (rapalogs, including everolimus, temsirolimus, and ridaforolimus) are FDA approved as mTOR in...
Autores principales: | Shi, Guoli, Chiramel, Abhilash I., Li, Tiansheng, Lai, Kin Kui, Kenney, Adam D., Zani, Ashley, Eddy, Adrian C., Majdoul, Saliha, Zhang, Lizhi, Dempsey, Tirhas, Beare, Paul A., Kar, Swagata, Yewdell, Jonathan W., Best, Sonja M., Yount, Jacob S., Compton, Alex A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753997/ https://www.ncbi.nlm.nih.gov/pubmed/36264642 http://dx.doi.org/10.1172/JCI160766 |
Ejemplares similares
-
Lessons in self-defence: inhibition of virus entry by intrinsic immunity
por: Majdoul, Saliha, et al.
Publicado: (2021) -
Restriction of Influenza A Virus by SERINC5
por: Lai, Kin Kui, et al.
Publicado: (2022) -
From rapalogs to anti-aging formula
por: Blagosklonny, Mikhail V.
Publicado: (2017) -
Opposing activities of IFITM proteins in SARS‐CoV‐2 infection
por: Shi, Guoli, et al.
Publicado: (2020) -
Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue
por: Shi, Guoli, et al.
Publicado: (2023)